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Abstract 
Osteoporotic fractures present a significant social and economic burden, which is set to rise 
commensurately with the aging population. Greater understanding of the physicochemical 
differences between osteoporotic and normal conditions will facilitate the development of 
diagnostic technologies with increased performance and treatments with increased efficacy. 
Using coherent X-ray scattering we have evaluated a population of 108 ex vivo human bone 
samples comprised of non-fracture and fracture groups. Principal component fed linear 
discriminant analysis was used to develop a classification model to discern each condition 
resulting in a sensitivity and specificity of 93% and 91%, respectively. Evaluating the coherent X-
ray scatter differences from each condition supports the hypothesis that a causal physicochemical 
change has occurred in the fracture group. This work is a critical step along the path towards 
developing an in vivo diagnostic tool for fracture risk prediction. 
 
Introduction 
There is a growing need to understand and quantify the condition of osteoporotic and normal 
tissues at the atomic level and the concomitant differences at the physicochemical level. This 
information is required to support and inform the development of accurate diagnostics capable of 
enhanced discrimination. Osteoporosis is a systemic skeletal condition characterised by low bone 
mass and the micro-architectural deterioration of bone tissue, with a consequent increase in 
bone fragility and susceptibility to fracture1. The increased fracture risk due to osteoporosis has a 
considerable impact on morbidity and mortality; it is a major health economic issue. It is 
estimated that one in three women over fifty years old will experience osteoporotic fractures, as 
will one in five men2. Even marginal improvements in diagnostic performance would be of very 
significant benefit3. Whilst osteoporosis related fractures can occur at any time their probability 
appears to increase exponentially with age4. Given the aging population it was estimated in 2011 
that by 2025, annual direct costs from osteoporosis in the US alone are expected to reach 
approximately $25.3 billion5.  
The diagnosis of osteoporosis is based upon the assessment of bone mass and quality6. However, 
Kanis (2002) argues that there are no satisfactory clinical means to assess bone quality and 
therefore diagnosis of osteoporosis depends upon the measurement of skeletal mass. Currently, 
in the clinical setting, skeletal mass is estimated by dual-energy X-ray absorptiometry (DEXA) 
which enables the calculation of bone mineral density (BMD). Bone strength and thus fracture 
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risk are correlated with BMD although only ~70% of the variation in compressive bone strength 
can be attributed to mineral density alone7. It therefore follows that establishing and measuring 
the factors attributed to the remaining ~30% would lead to the development of improved patient 
management and a reduced health burden. There is support in the literature that 
physicochemical properties of bone mineral (referred to as bone quality8) are also required for 
accurately predicting bone strength9, 10, 11, 12, 13, 14, 15, though the precise relationships between 
these properties remain elusive. The measurement of coherent X-ray scatter or diffraction, which 
for brevity is termed X-ray scatter in the remaining text, may be employed to calculate several 
factors associated with bone quality9 and more recently has shown potential for operation at 
diagnostically appropriate X-ray energies16, 17. These measurements are independent of 
conventional bone mineral density (DEXA scans) that provides estimates of the average areal 
density of all bone components. The scatter signatures arise almost entirely from the apatite 
mineral’s crystallographic periodicity and therefore may be considered orthogonal to BMD. 
We have collected X-ray scatter patterns from 108 bone samples (54 from individuals suffering 
from hip fractures and 54 from individuals with no fractures) and used this information in two 
different ways. First, to build a classification model that predicts each condition to produce a 
fracture and non-fracture group; and second, to evaluate which characteristics within the scatter 
patterns may be condition related. This approach was designed to further our understanding of 
the physicochemical changes that occur in osteoporotic tissue. Ultimately, our aim is to support 
and inform the ongoing development of an in vivo diagnostic technique to enhance fracture risk 
prediction. 
 
Results 
The fracture group comprised of 54 samples from 19 patients. The non-fracture group comprised 
54 samples from 54 individuals. A total number of 108 diffractograms were recorded; one for 
each sample. The min-max normalised mean diffractograms from each condition are illustrated in 
Figure 1. 
A 2-group principal component fed linear discriminant classification model was developed and 
applied to separate the fracture and non-fracture groups. Leave one sample out cross-validation 
demonstrated a sensitivity of 93% and a specificity of 91%. Figure 2 illustrates a histogram of 
linear discriminant scores for each diffractogram (colour codes for fracture and non-fracture 
groups), which demonstrates the potential diagnostic capability of X-ray scattering to separate 
these groups.  
This method was repeated on a subset of data to evaluate this approach for discriminating 
fracture and non-fracture groups between the sexes. Classification resulted in 89% sensitivity and 
89% specificity for males; 92% sensitivity and 89% specificity for females. Histograms of the linear 
discriminant scores for each sex are illustrated in Figure 3.  
In addition, our analysis was modified to provide an independent validation of this approach. We 
applied a leave one patient out cross-validation in which no samples from the test patient were 
included in the training model. The resultant sensitivity of 93% and a specificity of 91% were 
unchanged in comparison with the leave one sample out cross-validation method. 
It is unlikely that an XRD technique capable of making in vivo measurements16, 17 would be able to 
achieve the measurement fidelity provided by the conventional laboratory diffractometer 
employed in this study. To explore the implications likely of an in vivo system the classification 
analysis was repeated after re-interpolating the raw data with increased step sizes, see Table 1. 
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Further analysis was undertaken to evaluate the differences in the scatter patterns and thus by 
inference, the potential physicochemical differences upon which the classification was based. 
Principal component loadings e.g. analogous to correlation coefficients, provided the variable (in 
this case 2θ) explained by each component. Linear discriminant weights generated after linear 
discriminant analysis identified three principal components as being responsible significantly for 
the classification (p<0.05). A weighted sum of the associated PC loadings and thus a weighted 
sum of the variation in the scatter angle attributed to classification is illustrated in Figure 4. In this 
circumstance negative peaks are indicative of the fracture group and positive peaks are indicative 
of the non-fracture group. 
A number of the prominent peaks that appear important for discriminating between the groups 
are labelled with their crystallographic Miller indices.  
 
Discussion 
The performance of DEXA is at least as good at diagnosing osteoporosis as blood pressure is at 
predicting a stroke6, though consistent performance statistics are not available in the literature. 
Enhancements have already been introduced in the form of patient risk factors but we seek to 
include additional information from bone quality that cannot be measured by bone mineral 
density (BMD). 
The measurement of scattered X-rays from bone enables specific material characteristics of the 
mineral content to be determined. We recorded diffractograms from 108 bone samples ex vivo 
relating to fracture and non-fracture groups. Principal component fed linear discriminant analysis 
was selected as a multivariate approach to develop a classification model to distinguish between 
each group and by hypothesis each condition. This method was adopted as it provides specific 
information on the variance in the dataset and the relative importance of features in the 
diffractogram, i.e. it is not a black box method. These key components were then used to explore 
whether they could be used to discriminate conditions based upon maximising the between 
group variance and minimising the within group variance with kindest discrimination analysis. 
Classification performance was found to be extremely high, for this dataset, yielding a sensitivity 
and specificity of 93% and 91%, respectively. Repeating this analysis for each sex resulted in 
slightly better performance for female classification (92% sensitivity and 89% specificity) in 
comparison to male classification (89% sensitivity and 89% specificity), which is perhaps 
attributable to lower sample numbers for training. Importantly, this performance appears to 
exceed significantly that expected from DEXA in a clinical setting. Also, in these circumstances 
XRD and DEXA would provide independent assessments of fracture risk. Our conjecture is that by 
combining data from each technique it may be possible to improve significantly the overall 
performance of diagnostic testing. Techniques that have the potential to record X-ray scatter 
patterns in vivo are in their infancy. However, it is unlikely that even a more mature 
implementation applied to the femur would achieve the measurement fidelity provided by a 
laboratory diffractometer operating under ideal conditions. Emulating a reduction in 
measurement fidelity, see Table 1, did not reduce significantly the classification performance. 
This is a promising result with regard our planned in vivo studies and an important step along the 
path to the implementation of an in vivo instrument.  
Understanding the signal characteristics that underpin the classification and thus identify possible 
physicochemical changes between conditions is paramount as it could lead to the development of 
treatments with increased efficacy. Figure 4 illustrates the peaks in the coherently scattered X-ray 
intensity that contributes most significantly to the classification. In general, the quantity of 
scattering from the non-fracture group was greater than that from the fracture group. This 
observation is attributed to a systemic difference in the mass of sample analysed i.e. the slightly 
different mechanical sampling regimes employed produced relatively more non-fracture sample 
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mass. The scatter data demonstrates a broad intensity peak at ~20o /2θ that is enhanced in the 
non-fracture group. The collagen helical rise per residue is ~0.29 nm and produces a broad peak 
at ~30o/2θ. Therefore a difference plot characteristic is more likely attributable to variations in 
the overall lipid content of the samples. Small methodological differences in the fat removal stage 
of the sample preparation may therefore account for this observation. Thus a subset of the 
scatter patterns with this peak excluded was evaluated. The performance of the classification was 
not affected significantly i.e. sensitivity and specificity of 89% and 85%, respectively, indicating 
that successful classification is not dependent upon this feature. 
Although bone performs biologically critical mechanical and homeostatic functions, the 
relationships between its hierarchical constituents are not well understood. The basis chemical 
composition (non-stoichiometric hydroxyapatite) crystallises into a variable ultra-structure (nano-
crystallites) that together with organic components form the fundamental building blocks of 
bone’s microarchitecture. Coherent X-ray scatter provides information specifically regarding the 
physicochemical characteristics of bone mineral. There is significant evidence from previous 
studies that bone mechanical properties (e.g. fragility) are affected by these physicochemical 
features9, although there remains controversy concerning the precise nature and magnitude of 
such relationships21. The composition of apatite is known to markedly affect its crystallite size and 
shape. For example, phosphate substitution by carbonate (bone apatite contains ~5 %wt CO3
2-) 
results in smaller, more rod like crystallites than the corresponding unsubstituted chemistry22 as 
the increase in lattice disorder produces increased solubility of the crystallites23. This type of 
substitution must be accompanied by heteroionic exchange or vacancies at the anionic calcium 
sites for charge balance. 
Within this study, there are a number of differences associated clearly with the Bragg maxima 
arising specifically from the nano-crystalline, mineral apatite. In general, such differences can 
arise from systematic shifts in peak positions and/or intensity changes (both indicative of apatite 
unit cell modification) and peak shape variation (suggestive of microstructural revisions). 
Unfortunately, X-ray diffraction from nano-crystalline materials with relatively low symmetry, 
such as biological apatite, is characterised by significant Bragg peak overlapping and thus 
equivocally associating features of difference plots with specific structural differences is 
problematic. For example, features within Figure 4 at scatter angles between 30-35 0/2are 
consistent with both microstructural and cell dimension differences between the groups although 
both are indicative of lattice substitutions. Reduced crystallite size of bone mineral has previously 
been associated with decreased load accommodation and increased fracture risk24 and is 
observed consistently in pathologies such as osteoporosis imperfecta25. It has also been proposed 
that an ‘optimal’ crystallite size corresponds to maximum bone strength10. 
Our results also show that the Bragg peak intensity differences are related to specific 
crystallographic directions; planes normal to the basal plane produce increased intensity within 
the non-fracture group. This aspect may be related to systemic differences within the unit cell 
chemistry. For example, the effect of reducing the Ca2+ occupancy (or electron density for those 
ions at the channel sites) is to increase the structure factor of the 002 and 004 reflections and 
decrease the corresponding amplitude of scatter for the 310. This is entirely consistent with the 
observations of this study and indicates possible specific differences in apatite chemistry between 
the fracture and non-fracture groups. Disorder within the apatite lattice, as introduced by such 
lattice site modifications, has been proposed as a fundamental contributor to bone mechanical 
compromise for more than three decades26 and evidence for this hypothesis continues to be 
reported27. Consequently, the chemical composition of bone apatite through its influence on 
crystallite dimensions and subsequently micro-architecture is a significant determinant of bone 
mechanical performance. Thus these features may influence coherent scatter measurements to 
distinguish between bones with different fragilities. 
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Methods 
Bone Samples A total of 19 femoral heads, from individuals who had suffered trauma fractures at 
the femoral neck, were donated by patients after they had undergone hip replacement surgery. 
From these, 54 samples were taken randomly across the femoral head to comprise our fracture 
group. Ethical approval was provided by the Gloucestershire NHS Local Research Ethics 
Committee.   The non-fracture group derived from the femoral heads of 54 individuals donated 
from the Melbourne Femur Collection. Informed consent was obtained from the next of kin in 
strict accordance with Australian National Health and Medical Research Council guidelines and 
prevailing local legislation, and ethics approval provided by the University of Melbourne. All 
methods in handling the material for the work reported in this paper were carried out in 
accordance with the approved guidelines and the appropriate standards applying in this medico-
legal context. Further details are provided in the Acknowledgements. 
The Australian and UK donors were all taken from an Anglo-Celtic population with a common 
Western lifestyle. A demographic break down of the samples is illustrated in Table 2.  
Sample Preparation The precise cleaning procedure for the fracture group samples has been 
detailed elsewhere18, but in summary each sample was subject to a high pressure jet wash and 
soaked in 1:1 mix of chloroform and methanol to remove fat. All bone samples were 
homogenised using a Retsch mixer miller (mm 2000) with zirconium milling baskets and balls. 
Each sample was sectioned (to reduce milling time) and milled in 60 second cycles with a 60 
second rest period between cycles to prevent overheating (which is known to affect 
crystallinity19). The samples were then sieved through a 106 µm stainless steel mesh to ensure 
homogeneity. 
X-ray Scattering The angular distribution of the X-ray scatter was measured using conventional X-
ray diffraction (XRD) methods. Samples were loaded into holders made from low-background off-
cut silicon. To correct for differences in sample position, each sample was spiked with a small 
amount of silicon powder (NIST SRM640c). Systematic peak shifts due to sample position were 
corrected as a post processing step and re-interpolated onto a common scatter angle (2θ) scale. 
The XRD analysis was conducted by a PANalytical X’pert Pro Diffractometer with Cu target 
operating at 40 keV and 40 mA. A PIXcel strip detector collected scattered photons from 10-80o 
2θ in 0.013o steps with an equivalent integration time of 150 seconds per point. 
Statistical Analysis Silicon peaks were removed from each diffractogram as a pre-processing step 
to ensure that any small differences in the levels of dopant would not bias classification. Each 
diffractogram was normalised and mean centred by subtracting the mean of all diffractograms 
from each individual diffractogram. Principal component fed linear discriminant analysis was 
employed to develop a classification model in Matlab®. Principal components (PCs) were 
generated that simplified the data while retaining the salient information required for 
classification. Each PC was tested with analysis of variance (ANOVA) and PCs with a high 
significance (p<0.05) for classification were selected for inclusion in the linear discriminant 
analysis (LDA) models. Leave-one-out cross-validation and linear discriminant analysis was used 
to calculate sensitivity and specificity20. This analysis involved the exclusion of one sample at a 
time and a full recalculation of the mean-centring, PCs and ANOVA selection of significant PCs, 
prior to projection of the ‘independent’ sample onto the model for prediction of fracture/non-
fracture group. This process was repeated for each sample. 
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Step Size (o) Sensitivity (%) Specificity (%) 
0.013 93 91 
0.1 93 91 
1 89 87 
2 87 85 
 
Table 1: Classification performance of identifying fracture and non-fracture groups from X-ray 
scatter patterns when re-interpolated at increasing step sizes. 
 
 
 Fracture Non-Fracture 
Males Females Males Females 
Samples 18 36 27 27 
Donors 4 15 27 27 
Age range 74-78 73-90 66-93 60-90 
 
Table 2. Ex vivo bone sample demographic break down. 
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Figure 1: Comparison of min-max normalised mean diffractograms from fracture and non-
fracture bone samples, where 2θ is the angle subtended by the trajectory of the diffracted or 
scattered X-rays with respect to the interrogating beam. The plots are offset along the vertical 
axis for clarity. 
 
 
Figure 2: Two group histogram demonstrating classification performance of the two group model; 
non-fracture versus fracture. 
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Figure 3: Two group histogram demonstrating classification performance of the two group model; 
non-fracture versus fracture for males (a) and females (b). 
 
 
 
 
Figure 4: Sum of principal component loadings weighted by their significance at classifying 
fracture and non-fracture groups (using those weightings calculated by the linear discriminant 
analysis (LDA) model). 
 
